SinoMab Doses First Patient in Clinical Study of Atopic Dermatitis Drug in China
SinoMab Doses First Patient in Clinical Study of Atopic Dermatitis Drug in China
SinoMab在中國對特應性皮炎藥物進行了臨床研究並給第一位患者注射劑量
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊